Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Höfner

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Journal of the American Chemical Society|August 29, 2013
Deamination, oxidation, and C-C bond cleavage reactivity of 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxycytosineStefan Schiesser, Toni Pfaffeneder, Keyarash Sadeghian, et al.
Journal of the American Chemical Society|June 29, 2023
Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ ModulationSilvia Arifi, Julian A Marschner, Julius Pollinger, et al.
Toxicology Letters|January 12, 2024
MS Binding Assays with UNC0642 as reporter ligand for the MB327 binding site of the nicotinic acetylcholine receptorValentin Nitsche, Georg Höfner, Jesko Kaiser, et al.
Toxicology Letters|December 12, 2022
A novel binding site in the nicotinic acetylcholine receptor for MB327 can explain its allosteric modulation relevant for organophosphorus-poisoning treatmentJesko Kaiser, Christoph G W Gertzen, Tamara Bernauer, et al.
Toxicology Letters|May 20, 2024
Identification of ligands binding to MB327-PAM-1, a binding pocket relevant for resensitization of nAChRsJesko Kaiser, Christoph G W Gertzen, Tamara Bernauer, et al.
Toxicology Letters|May 17, 2024
Synthesis and biological evaluation of novel MB327 analogs as resensitizers for desensitized nicotinic acetylcholine receptors after intoxication with nerve agentsTamara Bernauer, Valentin Nitsche, Jesko Kaiser, et al.
Plos One|February 11, 2016
Azidobupramine, an Antidepressant-Derived Bifunctional Neurotransmitter Transporter Ligand Allowing Covalent Labeling and Attachment of FluorophoresThomas Kirmeier, Ranganath Gopalakrishnan, Vanessa Gormanns, et al.
British Journal of Pharmacology|May 4, 2026
Delivery of nano-formulated drugs to solid tumours is selectively increased by co-application of the vascular disrupting agent CA4PAnnabel Kitowski, Constanze Heise, Stefanie Sperling, et al.
European Journal of Medicinal Chemistry|January 25, 2023
Discovery of new, highly potent and selective inhibitors of BuChE - design, synthesis, in vitro and in vivo evaluation and crystallography studiesDawid Panek, Anna Pasieka, Gniewomir Latacz, et al.
European Journal of Medicinal Chemistry|April 10, 2021
Discovery of multifunctional anti-Alzheimer's agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transportersAnna Pasieka, Dawid Panek, Jakub Jończyk, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Journal of the American Chemical Society|August 29, 2013
Deamination, oxidation, and C-C bond cleavage reactivity of 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxycytosineStefan Schiesser, Toni Pfaffeneder, Keyarash Sadeghian, et al.
Journal of the American Chemical Society|June 29, 2023
Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ ModulationSilvia Arifi, Julian A Marschner, Julius Pollinger, et al.
Toxicology Letters|January 12, 2024
MS Binding Assays with UNC0642 as reporter ligand for the MB327 binding site of the nicotinic acetylcholine receptorValentin Nitsche, Georg Höfner, Jesko Kaiser, et al.
Toxicology Letters|December 12, 2022
A novel binding site in the nicotinic acetylcholine receptor for MB327 can explain its allosteric modulation relevant for organophosphorus-poisoning treatmentJesko Kaiser, Christoph G W Gertzen, Tamara Bernauer, et al.
Toxicology Letters|May 20, 2024
Identification of ligands binding to MB327-PAM-1, a binding pocket relevant for resensitization of nAChRsJesko Kaiser, Christoph G W Gertzen, Tamara Bernauer, et al.
Toxicology Letters|May 17, 2024
Synthesis and biological evaluation of novel MB327 analogs as resensitizers for desensitized nicotinic acetylcholine receptors after intoxication with nerve agentsTamara Bernauer, Valentin Nitsche, Jesko Kaiser, et al.
Plos One|February 11, 2016
Azidobupramine, an Antidepressant-Derived Bifunctional Neurotransmitter Transporter Ligand Allowing Covalent Labeling and Attachment of FluorophoresThomas Kirmeier, Ranganath Gopalakrishnan, Vanessa Gormanns, et al.
British Journal of Pharmacology|May 4, 2026
Delivery of nano-formulated drugs to solid tumours is selectively increased by co-application of the vascular disrupting agent CA4PAnnabel Kitowski, Constanze Heise, Stefanie Sperling, et al.
European Journal of Medicinal Chemistry|January 25, 2023
Discovery of new, highly potent and selective inhibitors of BuChE - design, synthesis, in vitro and in vivo evaluation and crystallography studiesDawid Panek, Anna Pasieka, Gniewomir Latacz, et al.
European Journal of Medicinal Chemistry|April 10, 2021
Discovery of multifunctional anti-Alzheimer's agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transportersAnna Pasieka, Dawid Panek, Jakub Jończyk, et al.
Pageof 10